Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Review · May 27, 2020

Risks and Impact of ACE Inhibitors or ARBs in COVID-19

Annals of Internal Medicine


Additional Info

Annals of Internal Medicine
Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults
Ann. Intern. Med 2020 May 15;[EPub Ahead of Print], K Mackey, VJ King, S Gurley, M Kiefer, E Liederbauer, K Vela, P Sonnen, D Kansagara

Further Reading